Natural history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: findings from the ISTH registry

Autor: Riva, N, Ageno, W, Schulman, S, Beyer-Westendorf, J, Bang, Sm, Pasca, S, Poli, D, Verhamme, P, Alatri, A, Colaizzo, D, Rancan, E, Rezende, Sm, Piana, A, Bazzan, M, De Sancho MT, Ciantar, E, Elli, E, Zawilska, K, Dentali, F

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3657::0f0e6436686997cab3a83752cdbc6160
http://hdl.handle.net/11577/3406290

Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.

Autor: Tardy B; Inserm CIC 1408, FCRIN-INNOVTE, CHU de Saint Etienne, Saint Etienne, France., Chalayer E; Inserm CIC 1408, FCRIN-INNOVTE, CHU de Saint Etienne, Saint Etienne, France., Kamphuisen PW; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., Ni Ainle F; Department of Haematology, Mater Misericordiae University Hospital Dublin, Dublin, Ireland., Verhamme P; Vascular Medicine and Haemostasis, University of Leuven, Leuven, Belgium., Varlet MN; Department of Gynecology and Obstetrics, University Hospital, Saint-Étienne, University Jean-Monnet, Saint-Étienne, France., Chauleur C; Department of Gynecology and Obstetrics, University Hospital, Saint-Étienne, University Jean-Monnet, Saint-Étienne, France., Rodger M; Department of Medicine, Division of Hematology, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada., Merah A; Inserm CIC 1408, FCRIN-INNOVTE, CHU de Saint Etienne, Saint Etienne, France., Buchmuller A; Inserm CIC 1408, FCRIN-INNOVTE, CHU de Saint Etienne, Saint Etienne, France.; Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, St-Etienne, France.; INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, St-Etienne, France.; FCRIN-INNOVTE, St-Etienne, France., Bistervels I; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands., De Sancho MT; Department of Medicine, Division of Hematology-Oncology, New York Presbyterian Hospital of Weill Cornell Medical College, New York, NY, USA., Middeldorp S; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands., Bertoletti L; Inserm CIC 1408, FCRIN-INNOVTE, CHU de Saint Etienne, Saint Etienne, France.; Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, St-Etienne, France.; INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, St-Etienne, France.; FCRIN-INNOVTE, St-Etienne, France.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2019 Nov; Vol. 17 (11), pp. 1979-1988. Date of Electronic Publication: 2019 Aug 12.

Outcomes in women receiving low-molecular-weight heparin during pregnancy.

Autor: De Sancho MT; Division of Hematology-Oncology, Department of Medicine, New York Presbyterian Hospital of Weill Cornell Medical College, New York, New York 10021, USA. mtd2002@med.cornell.edu, Khalid S, Christos PJ

Publikováno v: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2012 Dec; Vol. 23 (8), pp. 751-5.